Everyone now acknowledges that the health insurance exchanges aren’t working out quite like planned. Soon we may have some useful research on why that happened, but now we are still getting analyses revealing the depth of the problem, including one from the Brookings Institution that examined exchanges in six states. (Brookings Analysis) Here is what the authors found, based not just on looking at data but talking to stakeholders in each state. In Alaska there are only two competitors on the exchange and premiums are high. But Alaska is probably a special case, extremely rural and a low population and not much competition in the provider market. As in other states, the interviewees also emphasized low consumer knowledge and high confusion. In Florida there is a fair amount of competition in some areas, but premiums are high where there isn’t. Stakeholders identified ability to negotiate with providers as a key to lower prices. Kansas had relatively low premiums but expectations were for a 30% to 40% increase this year. There is not a great deal of competition, basically only two insurers selling on the exchange, but provider prices may be low enough to constrain premiums. North Carolina experienced low competition in the first year, but competition has grown, with insurers using narrower networks, tiered plans and provider risk-sharing to enhance their comfort with offering plans without losing their shirts. But as elsewhere, rural areas tend to have no competition and high premiums. Ohio had a number of health plan participants in most areas, but still had high premiums, which the stakeholders attributed to high provider pricing and little ability to negotiate. Texas had adequate competition and somewhat lower premiums. The common thread is a difficulty in attracting enough competition to all areas of a state, provider pricing and leverage that limits lowering of premiums, and low levels of consumer knowledge.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
It may be investors that need the redesign. They just keep pouring money into this digital health crap despite all the losses. Redesign Health claims that it makes money by...
September 16, 2022
In truth, this seems like more money down a rathole. Google’s parent and other investors are putting a billion dollars into Google’s health arm, Verily. Apparently want to compete with...
September 12, 2022
It is like investors have learned nothing from the past two years. Even supposedly smart investors like Morgan Health, which is making a $20 million contribution to LetsGetChecked, which supposedly...
September 12, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace